US20040087886A1 - Linearly expandable ureteral stent - Google Patents

Linearly expandable ureteral stent Download PDF

Info

Publication number
US20040087886A1
US20040087886A1 US10/283,873 US28387302A US2004087886A1 US 20040087886 A1 US20040087886 A1 US 20040087886A1 US 28387302 A US28387302 A US 28387302A US 2004087886 A1 US2004087886 A1 US 2004087886A1
Authority
US
United States
Prior art keywords
stent
elongated member
lumen
retention structure
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/283,873
Inventor
Barry Gellman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/283,873 priority Critical patent/US20040087886A1/en
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Assigned to SCIMED LIFE SYSTEMS, INC. reassignment SCIMED LIFE SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GELLMAN, BARRY N.
Priority to JP2004550158A priority patent/JP2006504487A/en
Priority to EP03779375.9A priority patent/EP1556115B1/en
Priority to CA002504150A priority patent/CA2504150A1/en
Priority to PCT/US2003/034214 priority patent/WO2004041345A1/en
Priority to AU2003285060A priority patent/AU2003285060A1/en
Publication of US20040087886A1 publication Critical patent/US20040087886A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCIMED LIFE SYSTEMS, INC.
Priority to US12/241,450 priority patent/US9060888B2/en
Priority to US12/628,289 priority patent/US10201441B2/en
Priority to US12/628,304 priority patent/US8007702B2/en
Priority to US13/205,440 priority patent/US8241548B2/en
Priority to US13/556,864 priority patent/US8568643B2/en
Priority to US16/223,375 priority patent/US11000391B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/008Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract

Definitions

  • the invention generally relates generally to medical devices for the drainage of fluids, and more specifically to ureteral stents.
  • a ureter is a tubular passageway in a human body that conveys urine from a kidney to a bladder.
  • the ureter begins with the renal pelvis and ends at the trigone region of the bladder, i.e., the triangulated area between both ureteral orifices and the bladder neck.
  • Urine is transported through the ureter under the influence of hydrostatic pressure, assisted by contractions of muscles located within the walls (lining) of the ureter.
  • Some patients experience a urological condition known as ureteral blockage or obstruction.
  • Some common causes of ureteral blockage are the formation of tumors or abnormalities within the ureteral lining, or the formation and passage of kidney stones.
  • Ureteral stents are used to facilitate urinary drainage from the kidneys to the bladder in patients having a ureteral obstruction or injury, or to protect the integrity of the ureter in a variety of surgical manipulations.
  • Stents may be used to treat or avoid ureter obstructions (such as ureteral stones or ureteral tumors) which disrupt the flow of urine from the kidneys to the bladder. Serious obstructions may cause urine to back up into the kidneys, threatening renal function.
  • Ureteral stents may also be used after endoscopic inspection of the ureter.
  • a stent may be uncomfortable to a patient because of intramural tunnel pain, imposed by the stent itself or in combination with intraoperative trauma inflicted from device passage. Pain may also be caused by urine reflux back up the ureter during increased bladder pressure, e.g., during voiding. Further, pain may stem from trigome irritation resulting from constant irritation, imposed by the bladder anchoring features or in combination with intraoperative trauma inflicted from device passage. Moreover, discomfort may arise from flank pain, caused by reflux or kidney anchoring.
  • Ureteral stents typically are tubular in shape, terminating in two opposing ends: a kidney distal end and a bladder proximal end.
  • Existing ureteral stents compensate for the motion between the kidney and bladder by employing a pair of coil end-effectors, with one effector placed in the bladder proximal end and the other in the kidney distal end. As motion occurs, the ureter slides up and down the stent body. Any other travel results in an uncurling of the end effector(s).
  • Discomfort may be related to the stent rubbing against a wall of the ureter, caused by the constant relative motion between the kidney and the bladder. This motion may be as much as 5 centimeters (cm) (approximately 2 inches) and cycles with each breath of the patient. This is equal to approximately 17,000 cycles per day, assuming 1 breath every 5 seconds.
  • the present invention alleviates discomfort by providing a stent that, like the ureter, linearly expands and contracts in response to relative motion between the kidney and the bladder, thereby reducing friction caused by a stent rubbing against a wall of the ureter.
  • the invention features a ureteral stent having an elongated member defining a lumen.
  • the member has a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen.
  • a distal retention structure is connected to a distal end of the elongated member for retention in a kidney, and a proximal retention structure is connected to a proximal end of the elongated member for retention in a bladder.
  • the member includes a spring having a spring force of less than one pound.
  • the member includes a wire spring.
  • the wire spring includes a metal alloy, that may include at least one of titanium, nickel, copper, cobalt, vanadium, and iron.
  • the metal alloy includes nitonol.
  • the wire spring is coated with a polymer.
  • the polymer includes at least one of urethane, nylon, thermoplastic polyurethane (TPU), thermoplastic polyester elastomer, polyethyl, and silicone.
  • the stent has an elongated member including a tube having the solid sidewall and defining the lumen.
  • the spiral-shaped opening is defined by a slit formed in the sidewall of the tube.
  • the elongated member may include a polymer, such as at least one of urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone.
  • the elongated member includes an inner liner and an outer cover.
  • a wire spring is sandwiched between the inner liner and the outer cover, with the spiral-shaped opening being defined by slits formed in the inner liner and the outer cover, between a plurality of coils of the wire spring.
  • the wire spring includes a metal alloy including, e.g., at least one of titanium, nickel, copper, cobalt, vanadium, and iron.
  • the metal alloy includes nitonol.
  • At least one of the inner liner and the outer cover includes a polymer.
  • the polymer includes at least one of urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone.
  • a removable introducer is sized for placement within the lumen.
  • a ureteral stent in another aspect of the invention, includes an elongated member defining a lumen, the member having a solid sidewall with at least one slit formed therein such that the member is linearly expandable along a longitudinal axis of the lumen.
  • a distal retention structure is connected to a distal end of the elongated member for retention in a kidney, and a proximal retention structure is connected to a proximal end of the elongated member for retention in a bladder.
  • a method of facilitating urinary drainage from a kidney to a bladder in a patient that reduces discomfort to the patient includes positioning a ureteral stent in a ureter of a patient, the ureteral stent having an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen, a distal retention structure connected to a distal end of the elongated member for retention in the kidney, and a proximal retention structure connected to a proximal end of the elongated member for retention in the bladder.
  • the elongated member is allowed to linearly expand and contract between an expanded position and a retracted position, based on at least one of: relative positioning of organs within the patient, a breathing pattern of the patient, and relative positions of the kidney and the bladder.
  • the elongated member can be biased to the retracted position.
  • a method of manufacturing a linearly expandable ureteral stent includes providing an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen.
  • the stent also includes a distal retention structure and a proximal retention structure. The distal retention structure is connected to a distal end of the elongated member, and the proximal retention structure is connected to a proximal end of the elongated member.
  • Providing the elongated member includes providing a wire spring.
  • Providing the wire spring includes coating the wire spring with a polymer.
  • Providing the wire spring includes sandwiching the wire spring between an inner lining and an outer cover.
  • the inner lining and outer cover include extruded sheets.
  • the inner lining and outer cover are shrunk, and slits are formed through the inner lining and outer cover between a plurality of coils of the wire spring.
  • the inner lining and the outer cover are melted, and slits are formed through the inner lining and outer cover between a plurality of coils of the wire spring.
  • the elongated member is provided by forming a tube including a polymer, and forming a spiral slit through the tube.
  • a method of placing a ureteral stent in a patient includes providing a ureteral stent.
  • the ureteral stent includes an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen.
  • the ureteral stent also includes a distal retention structure connected to a distal end of the elongated member, and a proximal retention structure connected to a proximal end of the elongated member. The ureteral stent is inserted into a ureter of the patient.
  • the ureteral stent is positioned in the patient with the distal retention structure substantially within the kidney of the patient, the elongated member substantially within the intramural tunnel portion of the ureter, and the proximal retention structure substantially within the bladder of the patient.
  • the ureteral stent can further include a removable introducer sized to fit within the lumen and inserting the ureteral stent includes inserting the stent with the removable introducer into the ureter.
  • FIG. 1A is a schematic view of a human urinary tract, illustrating the placement of one embodiment of the invention within the ureter of a patient, in an expanded position;
  • FIGS. 1 B- 1 C are detailed sectional views of a portion of the embodiment of the invention of FIG. 1A;
  • FIGS. 2 A- 2 B are schematic representations of the embodiment of the invention illustrated in FIGS. 1 A- 1 C in a retracted position;
  • FIGS. 3 A- 3 B are schematic representations of another embodiment of the invention in an expanded position
  • FIGS. 4 A- 4 C are schematic representations of the embodiment of the invention illustrated in FIGS. 3 A- 3 B in a retracted position;
  • FIGS. 5 A- 5 C are schematic representations of yet another embodiment of the invention at various stages of fabrication
  • FIGS. 6 A- 6 C are schematic representations of yet another embodiment of the invention in retracted and expanded positions.
  • FIG. 7 is a schematic representation of an introducer.
  • the invention features temporary ureteral stents that, when positioned within the ureter of a patient, significantly reduce discomfort to the patient.
  • proximal refers to the end of a stent closest to a medical professional when placing a stent in a patient.
  • distal refers to the end of a stent furthest from a medical professional when placing a stent in a patient.
  • a human urinary tract 100 includes a ureter 105 that transports urine from a kidney 110 to a bladder 115 .
  • ureter 105 becomes blocked or obstructed due to, for example, post-kidney stone fragmentation/removal and ureteral stricture therapy, fluid drainage can become restricted.
  • Ureteral stents are medical devices that are implanted within ureter 105 to restore patency and fluid drainage.
  • a ureteral stent 120 is located within the ureter 105 of a patient, with a distal retention structure 125 in a pelvis 130 of kidney 110 , and a proximal retention structure 135 in the bladder 115 , proximate ureteral orifice 136 .
  • a lumen 137 extends within distal retention structure 25 , an elongated member 140 , and proximal retention structure 135 to provide for the passage of fluid.
  • Distal retention structure 125 is connected to a distal end 142 of elongated member 120
  • proximal retention structure 135 is connected to a proximal end 144 of elongated member 140 .
  • Distal retention structure 125 secures distal end 142 of elongated member in or proximate to kidney 110 .
  • Proximal retention structure 135 secures proximal end 144 of elongated member 140 in or proximate bladder 115 , as well as facilitates the removal of stent 120 by providing a loop suitable for grasping by a hook.
  • Distal retention structure 125 and proximal retention structure 135 can be fabricated of materials such as nylon, polyurethane, or the like. Heat bonding of these materials to elongated member 140 is conveniently accomplished by, for example, using an RF heat source as is commonly employed for plastic tubes and catheters.
  • the desired shape of distal and proximal retention structures 125 , 135 can be formed by injection molding or extrusion. They can also be heat-formed, for example, by flaring the working piece over an anvil of an appropriate shape, with the application of heat.
  • the shape of distal retention structure 125 can be, for example, a coil, a pig-tail coil, J-shaped, or a helical coil.
  • proximal retention structure 135 can be, for example, a coil, a pig-tail coil, J-shaped or a helical coil. In the illustrated embodiment, both distal and proximal retention structures 125 , 135 are J-shaped.
  • elongated member 140 includes a tube 145 having a solid sidewall 150 .
  • a slit 155 is formed in sidewall 150 , defining a spiral-shaped opening 160 , so that elongated member 140 is linearly expandable along a longitudinal axis 165 of lumen 137 .
  • Elongated member 140 can be formed from a polymer, such as, e.g., urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone.
  • Elongated member 140 can be manufactured by, for example, injection molding or extrusion and optionally a combination of subsequent machining operations. Extrusion processes, for example, can be used to provide a uniform shape, such as a single monolithic tube. Spiral-shaped opening 160 can be created in the desired locations by a subsequent machining operation.
  • elongated member 140 is linearly expandable between an expanded position (see, e.g., FIGS. 1 A- 1 B) and a retracted position (see FIGS. 2 A- 2 B).
  • spiral-shaped opening 160 is closed.
  • a difference in an expanded length L 1 of elongated member 140 in its expanded position and a retracted length L 2 of elongated member 140 in its retracted position can be approximately 5 cm (approximately 2 inches).
  • elongated member 140 can be sized so that retracted length L 2 is approximately 8 cm to 30 cm, and expanded length L 1 is approximately 13 cm to 35 cm.
  • Elongated member 140 can have, in its retracted position, an outer diameter d 1 corresponding to approximately 3.7 French to 14.0 French.
  • Lumen 137 can have a diameter d 2 of ______ when elongated member 140 is in its retracted position, to allow the introduction of a guide wire.
  • elongated member 140 can expand linearly up to 2 inches to expanded length L 1 , to provide comfort to the patient by compensating for at least one of: relative positioning of organs within the patient, a breathing pattern of the patient, and relative positions of kidney 110 and bladder 115 . Because of the possibility of linear expansion, a physician may be able to select ureteral stent 120 with a smaller size than would be required with a conventional stent.
  • ureteral stent 300 has an elongated member 310 including a spring 315 .
  • Distal retention structure 125 is connected to a distal end 312 of elongated member 310
  • proximal retention structure 135 is connected to a proximal end 314 of elongated member 310 .
  • Spring 315 has a plurality of coils 320 having, in some embodiments, a spring force less than one pound.
  • Spring 315 includes a wire 325 formed from a superelastic material. Materials with superelastic properties make it possible to configure a component into a particular shape, such as a coil or a sleeve, and then modify reversibly the geometry of the component, such as by straightening it out. Once the device is straightened, after removal of the straightening force, the component reverts spontaneously to its predetermined configuration, thereby regaining its former geometry. In so doing, the component provides a biasing force back to its original configuration.
  • Superelastic materials can include alloys of In—Ti, Fe—Mn, Ni—Ti, Ag—Cd, Au—Cd, Au—Cu, Cu—Al—Ni, Cu—Au—Zn, Cu—Zn—Al, Cu—Zn—Sn, Cu—Zn—Xe, Fe 3 Be, Fe 3 Pt, Ni—Ti—V, Fe—Ni—Ti—Co, and Cu—Sn.
  • wire 325 includes a superelastic material comprising a nickel and titanium alloy, known commonly as nitinol, available from Memory Corp. of Brookfield, Conn. or SMA Inc. of San Jose, Calif.
  • the ratio of nickel and titanium in nitinol can be varied. Examples include a ratio of about 50% to about 52% nickel by weight, or a ratio of about 48% to about 50% titanium by weight. Nitinol has shape retention properties in its superelastic phase.
  • Wire 320 can have a coating 330 including a biocompatible material, such as a polymer like urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, or silicone. Coating 330 can be applied to wire 320 by various methods, such as spray coating or painting.
  • a biocompatible material such as a polymer like urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, or silicone.
  • Coating 330 can be applied to wire 320 by various methods, such as spray coating or painting.
  • Ureteral stent 300 has an expanded position (see, e.g., FIGS. 3 A- 3 B) and a retracted position (see, e.g., FIGS. 4 A- 4 C).
  • coils 320 In the retracted position, coils 320 abut each other, defining a lumen 332 that is substantially enclosed.
  • coils 320 In the expanded position, coils 320 define a spiral-shaped opening 335 , formed by a plurality of gaps 340 between coils 320 .
  • Elongated member 310 is linearly expandable along a longitudinal axis 345 of lumen 332 .
  • a stent 500 is formed by placing a wire spring 510 , having a plurality of coils 512 , between an inner lining 515 and an outer cover 520 .
  • Wire spring 510 can be made from a metal alloy including, for example, titanium, nickel, copper, cobalt, vanadium, or iron.
  • the metal alloy can include nitonol, a material including nickel and titanium.
  • Inner lining 515 and outer cover 520 can each be formed from an extruded sheet.
  • Inner lining 515 and outer cover 520 can each be made from a polymer, such as urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone.
  • Inner lining 515 and outer cover 520 are deformed at elevated temperatures to fully surround wire spring 510 .
  • inner lining 515 and outer cover 520 can be shrunk by, e.g., exposure to a heat lamp.
  • inner lining 515 and outer cover 520 can be melted by, e.g., heating in an oven.
  • a plurality of slits 525 are formed through inner lining 515 and outer cover 520 between coils 512 to form an elongated member 530 .
  • Elongated member 530 is linearly expandable along a longitudinal axis 535 of a lumen 540 extending through elongated member 530 .
  • Elongated member 530 is connected at a distal end 545 to a distal retention structure 125 , and at a proximal end 555 to a proximal retention structure 135 .
  • a stent 600 has an elongated member 610 connected to distal retention structure 125 for retention in a kidney and proximal retention structure 135 for retention in a bladder.
  • Elongated member 610 defines a lumen 620 , and has a solid sidewall 625 .
  • Solid sidewall 625 can be made of a biocompatible material, such as a polymer, e.g., urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, or silicone.
  • Solid sidewall 625 has at least one slit 630 formed in it, so that elongated member 610 is linearly expandable along a longitudinal axis 635 of lumen 620 .
  • the invention provides an apparatus for delivering a stent into a patient.
  • An introducer 700 includes a guide wire 710 .
  • a proximal end 720 of guide wire 710 includes a grip 725 to assist in using the device.
  • a stent (e.g., stent 120 ) is mounted on introducer 700 .
  • Distal retention structure 125 is threaded over guide wire 710 , and most of its inherent curvature is removed.
  • the guide wire 710 is inserted into bladder 115 through ureteral orifice 136 up ureter 105 , and into kidney 110 .
  • a pusher (not shown) is then moved along guide wire 710 , pushing stent 120 along guide wire 710 towards kidney 110 .
  • Proximal end 144 of elongated member 140 can be positioned either at or distal to ureteral orifice 136 .
  • Stent 120 can also be positioned such that proximal retention structure 135 is at or distal to ureteral orifice 136 .
  • stent 120 Once the surgeon has achieved the desired positioning of stent 120 , guide wire 710 is removed, while holding the pusher stationary to maintain stent 120 in position. Finally, the pusher is removed from within the patient, leaving stent 120 in place.
  • the stent of the invention can be precisely positioned within ureter 105 of the patient. The method can also be used to accurately position proximal retention structure 135 in bladder 115 , and distal retention structure 125 within kidney 110 .
  • the guide wire, pusher, and stent are inserted into ureter 105 percutaneously through a surgical opening. In another embodiment, they are inserted into the ureter via the urinary tract of the patient.

Abstract

A ureteral stent including an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen. A distal retention structure is connected to a distal end of the elongated member for retention in a kidney. A proximal retention structure is connected to a proximal end of the elongated member for retention in a bladder.

Description

    FIELD OF THE INVENTION
  • The invention generally relates generally to medical devices for the drainage of fluids, and more specifically to ureteral stents. [0001]
  • BACKGROUND OF THE INVENTION
  • A ureter is a tubular passageway in a human body that conveys urine from a kidney to a bladder. The ureter begins with the renal pelvis and ends at the trigone region of the bladder, i.e., the triangulated area between both ureteral orifices and the bladder neck. Urine is transported through the ureter under the influence of hydrostatic pressure, assisted by contractions of muscles located within the walls (lining) of the ureter. Some patients experience a urological condition known as ureteral blockage or obstruction. Some common causes of ureteral blockage are the formation of tumors or abnormalities within the ureteral lining, or the formation and passage of kidney stones. [0002]
  • Ureteral stents are used to facilitate urinary drainage from the kidneys to the bladder in patients having a ureteral obstruction or injury, or to protect the integrity of the ureter in a variety of surgical manipulations. Stents may be used to treat or avoid ureter obstructions (such as ureteral stones or ureteral tumors) which disrupt the flow of urine from the kidneys to the bladder. Serious obstructions may cause urine to back up into the kidneys, threatening renal function. Ureteral stents may also be used after endoscopic inspection of the ureter. [0003]
  • A stent may be uncomfortable to a patient because of intramural tunnel pain, imposed by the stent itself or in combination with intraoperative trauma inflicted from device passage. Pain may also be caused by urine reflux back up the ureter during increased bladder pressure, e.g., during voiding. Further, pain may stem from trigome irritation resulting from constant irritation, imposed by the bladder anchoring features or in combination with intraoperative trauma inflicted from device passage. Moreover, discomfort may arise from flank pain, caused by reflux or kidney anchoring. [0004]
  • Ureteral stents typically are tubular in shape, terminating in two opposing ends: a kidney distal end and a bladder proximal end. Existing ureteral stents compensate for the motion between the kidney and bladder by employing a pair of coil end-effectors, with one effector placed in the bladder proximal end and the other in the kidney distal end. As motion occurs, the ureter slides up and down the stent body. Any other travel results in an uncurling of the end effector(s). [0005]
  • SUMMARY OF THE INVENTION
  • It is an objective of the invention to provide a patient, male or female, with a flexible device designed to maintain the patency of the ureter and enable fluid drainage while minimizing the pains and discomfort commonly associate with an in-dwelling device. [0006]
  • Discomfort may be related to the stent rubbing against a wall of the ureter, caused by the constant relative motion between the kidney and the bladder. This motion may be as much as 5 centimeters (cm) (approximately 2 inches) and cycles with each breath of the patient. This is equal to approximately 17,000 cycles per day, assuming 1 breath every 5 seconds. The present invention alleviates discomfort by providing a stent that, like the ureter, linearly expands and contracts in response to relative motion between the kidney and the bladder, thereby reducing friction caused by a stent rubbing against a wall of the ureter. [0007]
  • In one aspect, the invention features a ureteral stent having an elongated member defining a lumen. The member has a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen. A distal retention structure is connected to a distal end of the elongated member for retention in a kidney, and a proximal retention structure is connected to a proximal end of the elongated member for retention in a bladder. [0008]
  • One or more of the following features may also be included. The member includes a spring having a spring force of less than one pound. The member includes a wire spring. The wire spring includes a metal alloy, that may include at least one of titanium, nickel, copper, cobalt, vanadium, and iron. The metal alloy includes nitonol. The wire spring is coated with a polymer. The polymer includes at least one of urethane, nylon, thermoplastic polyurethane (TPU), thermoplastic polyester elastomer, polyethyl, and silicone. [0009]
  • The stent has an elongated member including a tube having the solid sidewall and defining the lumen. The spiral-shaped opening is defined by a slit formed in the sidewall of the tube. The elongated member may include a polymer, such as at least one of urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone. [0010]
  • The elongated member includes an inner liner and an outer cover. A wire spring is sandwiched between the inner liner and the outer cover, with the spiral-shaped opening being defined by slits formed in the inner liner and the outer cover, between a plurality of coils of the wire spring. The wire spring includes a metal alloy including, e.g., at least one of titanium, nickel, copper, cobalt, vanadium, and iron. The metal alloy includes nitonol. At least one of the inner liner and the outer cover includes a polymer. The polymer includes at least one of urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone. [0011]
  • A removable introducer is sized for placement within the lumen. [0012]
  • In another aspect of the invention, a ureteral stent includes an elongated member defining a lumen, the member having a solid sidewall with at least one slit formed therein such that the member is linearly expandable along a longitudinal axis of the lumen. A distal retention structure is connected to a distal end of the elongated member for retention in a kidney, and a proximal retention structure is connected to a proximal end of the elongated member for retention in a bladder. [0013]
  • In yet another aspect of the invention, a method of facilitating urinary drainage from a kidney to a bladder in a patient that reduces discomfort to the patient includes positioning a ureteral stent in a ureter of a patient, the ureteral stent having an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen, a distal retention structure connected to a distal end of the elongated member for retention in the kidney, and a proximal retention structure connected to a proximal end of the elongated member for retention in the bladder. The elongated member is allowed to linearly expand and contract between an expanded position and a retracted position, based on at least one of: relative positioning of organs within the patient, a breathing pattern of the patient, and relative positions of the kidney and the bladder. In addition, the elongated member can be biased to the retracted position. [0014]
  • In yet another aspect of the invention, a method of manufacturing a linearly expandable ureteral stent includes providing an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen. The stent also includes a distal retention structure and a proximal retention structure. The distal retention structure is connected to a distal end of the elongated member, and the proximal retention structure is connected to a proximal end of the elongated member. [0015]
  • The following features may be included. Providing the elongated member includes providing a wire spring. Providing the wire spring includes coating the wire spring with a polymer. Providing the wire spring includes sandwiching the wire spring between an inner lining and an outer cover. The inner lining and outer cover include extruded sheets. The inner lining and outer cover are shrunk, and slits are formed through the inner lining and outer cover between a plurality of coils of the wire spring. The inner lining and the outer cover are melted, and slits are formed through the inner lining and outer cover between a plurality of coils of the wire spring. The elongated member is provided by forming a tube including a polymer, and forming a spiral slit through the tube. [0016]
  • In yet another aspect of the invention, a method of placing a ureteral stent in a patient includes providing a ureteral stent. The ureteral stent includes an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen. The ureteral stent also includes a distal retention structure connected to a distal end of the elongated member, and a proximal retention structure connected to a proximal end of the elongated member. The ureteral stent is inserted into a ureter of the patient. The ureteral stent is positioned in the patient with the distal retention structure substantially within the kidney of the patient, the elongated member substantially within the intramural tunnel portion of the ureter, and the proximal retention structure substantially within the bladder of the patient. In a detailed embodiment, the ureteral stent can further include a removable introducer sized to fit within the lumen and inserting the ureteral stent includes inserting the stent with the removable introducer into the ureter. [0017]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention. [0018]
  • FIG. 1A is a schematic view of a human urinary tract, illustrating the placement of one embodiment of the invention within the ureter of a patient, in an expanded position; [0019]
  • FIGS. [0020] 1B-1C are detailed sectional views of a portion of the embodiment of the invention of FIG. 1A;
  • FIGS. [0021] 2A-2B are schematic representations of the embodiment of the invention illustrated in FIGS. 1A-1C in a retracted position;
  • FIGS. [0022] 3A-3B are schematic representations of another embodiment of the invention in an expanded position;
  • FIGS. [0023] 4A-4C are schematic representations of the embodiment of the invention illustrated in FIGS. 3A-3B in a retracted position;
  • FIGS. [0024] 5A-5C are schematic representations of yet another embodiment of the invention at various stages of fabrication;
  • FIGS. [0025] 6A-6C are schematic representations of yet another embodiment of the invention in retracted and expanded positions; and
  • FIG. 7 is a schematic representation of an introducer.[0026]
  • DETAILED DESCRIPTION
  • The invention features temporary ureteral stents that, when positioned within the ureter of a patient, significantly reduce discomfort to the patient. As used herein, proximal refers to the end of a stent closest to a medical professional when placing a stent in a patient. As used herein, distal refers to the end of a stent furthest from a medical professional when placing a stent in a patient. [0027]
  • Referring to FIG. 1A, a human [0028] urinary tract 100 includes a ureter 105 that transports urine from a kidney 110 to a bladder 115. When ureter 105 becomes blocked or obstructed due to, for example, post-kidney stone fragmentation/removal and ureteral stricture therapy, fluid drainage can become restricted. Ureteral stents are medical devices that are implanted within ureter 105 to restore patency and fluid drainage. A ureteral stent 120 is located within the ureter 105 of a patient, with a distal retention structure 125 in a pelvis 130 of kidney 110, and a proximal retention structure 135 in the bladder 115, proximate ureteral orifice 136. A lumen 137 extends within distal retention structure 25, an elongated member 140, and proximal retention structure 135 to provide for the passage of fluid. Distal retention structure 125 is connected to a distal end 142 of elongated member 120, and proximal retention structure 135 is connected to a proximal end 144 of elongated member 140. Distal retention structure 125 secures distal end 142 of elongated member in or proximate to kidney 110. Proximal retention structure 135 secures proximal end 144 of elongated member 140 in or proximate bladder 115, as well as facilitates the removal of stent 120 by providing a loop suitable for grasping by a hook.
  • [0029] Distal retention structure 125 and proximal retention structure 135 can be fabricated of materials such as nylon, polyurethane, or the like. Heat bonding of these materials to elongated member 140 is conveniently accomplished by, for example, using an RF heat source as is commonly employed for plastic tubes and catheters. The desired shape of distal and proximal retention structures 125, 135 can be formed by injection molding or extrusion. They can also be heat-formed, for example, by flaring the working piece over an anvil of an appropriate shape, with the application of heat. The shape of distal retention structure 125 can be, for example, a coil, a pig-tail coil, J-shaped, or a helical coil. The shape of proximal retention structure 135 can be, for example, a coil, a pig-tail coil, J-shaped or a helical coil. In the illustrated embodiment, both distal and proximal retention structures 125, 135 are J-shaped.
  • Referring to FIGS. [0030] 1A-1C, elongated member 140 includes a tube 145 having a solid sidewall 150. A slit 155 is formed in sidewall 150, defining a spiral-shaped opening 160, so that elongated member 140 is linearly expandable along a longitudinal axis 165 of lumen 137. Elongated member 140 can be formed from a polymer, such as, e.g., urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone.
  • [0031] Elongated member 140 can be manufactured by, for example, injection molding or extrusion and optionally a combination of subsequent machining operations. Extrusion processes, for example, can be used to provide a uniform shape, such as a single monolithic tube. Spiral-shaped opening 160 can be created in the desired locations by a subsequent machining operation.
  • Referring also to FIGS. 2A and 2B, [0032] elongated member 140 is linearly expandable between an expanded position (see, e.g., FIGS. 1A-1B) and a retracted position (see FIGS. 2A-2B). When elongated member 140 is retracted, spiral-shaped opening 160 is closed. A difference in an expanded length L1 of elongated member 140 in its expanded position and a retracted length L2 of elongated member 140 in its retracted position can be approximately 5 cm (approximately 2 inches). For example, elongated member 140 can be sized so that retracted length L2 is approximately 8 cm to 30 cm, and expanded length L1 is approximately 13 cm to 35 cm. Elongated member 140 can have, in its retracted position, an outer diameter d1 corresponding to approximately 3.7 French to 14.0 French. Lumen 137 can have a diameter d2 of ______ when elongated member 140 is in its retracted position, to allow the introduction of a guide wire.
  • In use, [0033] elongated member 140 can expand linearly up to 2 inches to expanded length L1, to provide comfort to the patient by compensating for at least one of: relative positioning of organs within the patient, a breathing pattern of the patient, and relative positions of kidney 110 and bladder 115. Because of the possibility of linear expansion, a physician may be able to select ureteral stent 120 with a smaller size than would be required with a conventional stent.
  • Referring to FIGS. [0034] 3A-3B, in another embodiment, ureteral stent 300 has an elongated member 310 including a spring 315. Distal retention structure 125 is connected to a distal end 312 of elongated member 310, and proximal retention structure 135 is connected to a proximal end 314 of elongated member 310.
  • [0035] Spring 315 has a plurality of coils 320 having, in some embodiments, a spring force less than one pound. Spring 315 includes a wire 325 formed from a superelastic material. Materials with superelastic properties make it possible to configure a component into a particular shape, such as a coil or a sleeve, and then modify reversibly the geometry of the component, such as by straightening it out. Once the device is straightened, after removal of the straightening force, the component reverts spontaneously to its predetermined configuration, thereby regaining its former geometry. In so doing, the component provides a biasing force back to its original configuration.
  • Superelastic materials can include alloys of In—Ti, Fe—Mn, Ni—Ti, Ag—Cd, Au—Cd, Au—Cu, Cu—Al—Ni, Cu—Au—Zn, Cu—Zn—Al, Cu—Zn—Sn, Cu—Zn—Xe, Fe[0036] 3Be, Fe3Pt, Ni—Ti—V, Fe—Ni—Ti—Co, and Cu—Sn. Preferably, wire 325 includes a superelastic material comprising a nickel and titanium alloy, known commonly as nitinol, available from Memory Corp. of Brookfield, Conn. or SMA Inc. of San Jose, Calif. The ratio of nickel and titanium in nitinol can be varied. Examples include a ratio of about 50% to about 52% nickel by weight, or a ratio of about 48% to about 50% titanium by weight. Nitinol has shape retention properties in its superelastic phase.
  • [0037] Wire 320 can have a coating 330 including a biocompatible material, such as a polymer like urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, or silicone. Coating 330 can be applied to wire 320 by various methods, such as spray coating or painting.
  • [0038] Ureteral stent 300 has an expanded position (see, e.g., FIGS. 3A-3B) and a retracted position (see, e.g., FIGS. 4A-4C). In the retracted position, coils 320 abut each other, defining a lumen 332 that is substantially enclosed. In the expanded position, coils 320 define a spiral-shaped opening 335, formed by a plurality of gaps 340 between coils 320. Elongated member 310 is linearly expandable along a longitudinal axis 345 of lumen 332.
  • Referring to FIGS. [0039] 5A-5C, in another embodiment, a stent 500 is formed by placing a wire spring 510, having a plurality of coils 512, between an inner lining 515 and an outer cover 520. Wire spring 510 can be made from a metal alloy including, for example, titanium, nickel, copper, cobalt, vanadium, or iron. The metal alloy can include nitonol, a material including nickel and titanium. Inner lining 515 and outer cover 520 can each be formed from an extruded sheet. Inner lining 515 and outer cover 520 can each be made from a polymer, such as urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, and silicone.
  • [0040] Inner lining 515 and outer cover 520 are deformed at elevated temperatures to fully surround wire spring 510. For example, inner lining 515 and outer cover 520 can be shrunk by, e.g., exposure to a heat lamp. Alternatively, inner lining 515 and outer cover 520 can be melted by, e.g., heating in an oven. After deformation, a plurality of slits 525 are formed through inner lining 515 and outer cover 520 between coils 512 to form an elongated member 530. Elongated member 530 is linearly expandable along a longitudinal axis 535 of a lumen 540 extending through elongated member 530. Elongated member 530 is connected at a distal end 545 to a distal retention structure 125, and at a proximal end 555 to a proximal retention structure 135.
  • Referring to FIGS. [0041] 6A-6C, in yet another embodiment, a stent 600 has an elongated member 610 connected to distal retention structure 125 for retention in a kidney and proximal retention structure 135 for retention in a bladder. Elongated member 610 defines a lumen 620, and has a solid sidewall 625. Solid sidewall 625 can be made of a biocompatible material, such as a polymer, e.g., urethane, nylon, TPU, thermoplastic polyester elastomer, polyethyl, or silicone. Solid sidewall 625 has at least one slit 630 formed in it, so that elongated member 610 is linearly expandable along a longitudinal axis 635 of lumen 620.
  • Referring to FIG. 7, in another aspect, the invention provides an apparatus for delivering a stent into a patient. An [0042] introducer 700 includes a guide wire 710. A proximal end 720 of guide wire 710 includes a grip 725 to assist in using the device.
  • Referring to FIG. 7 and also to FIG. 1A, in use, a stent, (e.g., stent [0043] 120) is mounted on introducer 700. Distal retention structure 125 is threaded over guide wire 710, and most of its inherent curvature is removed. Next, the guide wire 710 is inserted into bladder 115 through ureteral orifice 136 up ureter 105, and into kidney 110. A pusher (not shown) is then moved along guide wire 710, pushing stent 120 along guide wire 710 towards kidney 110. Proximal end 144 of elongated member 140 can be positioned either at or distal to ureteral orifice 136. Stent 120 can also be positioned such that proximal retention structure 135 is at or distal to ureteral orifice 136.
  • Once the surgeon has achieved the desired positioning of [0044] stent 120, guide wire 710 is removed, while holding the pusher stationary to maintain stent 120 in position. Finally, the pusher is removed from within the patient, leaving stent 120 in place. Using this method, the stent of the invention can be precisely positioned within ureter 105 of the patient. The method can also be used to accurately position proximal retention structure 135 in bladder 115, and distal retention structure 125 within kidney 110.
  • In one embodiment of the invention, the guide wire, pusher, and stent are inserted into [0045] ureter 105 percutaneously through a surgical opening. In another embodiment, they are inserted into the ureter via the urinary tract of the patient.
  • While the invention has been particularly shown and described with reference to specific preferred embodiments, it should be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.[0046]

Claims (38)

What is claimed is:
1. A ureteral stent comprising:
an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen;
a distal retention structure connected to a distal end of the elongated member for retention in a kidney; and
a proximal retention structure connected to a proximal end of the elongated member for retention in a bladder.
2. The stent of claim 1 wherein the member comprises a spring having a spring force of less than one pound.
3. The stent of claim 2 wherein the member comprises a wire spring.
4. The stent of claim 3 wherein the wire spring comprises a metal alloy.
5. The stent of claim 4 wherein the metal alloy comprises at least one of titanium, nickel, copper, cobalt, vanadium, and iron.
6. The stent of claim 5 wherein the metal alloy comprises nitonol.
7. The stent of claim 6 wherein nitonol comprises nickel and titanium.
8. The stent of claim 7 wherein nitonol comprises about 50% to about 52% nickel.
9. The stent of claim 8 wherein nitonol comprises about 48% to about 50% titanium.
10. The stent of claim 3 wherein the wire spring is coated with a polymer.
11. The stent of claim 10 wherein the polymer comprises at least one of urethane, nylon, thermoplastic polyurethane (TPU), thermoplastic polyester elastomer, polyethyl, and silicone.
12. The stent of claim 1 wherein the elongated member comprises a tube having the solid sidewall and defining the lumen, and the spiral-shaped opening is defined by a slit formed in the sidewall of the tube.
13. The stent of claim 12 wherein the elongated member comprises a polymer.
14. The stent of claim 13 wherein the polymer comprises at least one of urethane, nylon, thermoplastic polyurethane (TPU), thermoplastic polyester elastomer, polyethyl, and silicone.
15. The stent of claim 1 wherein the elongated member comprises an inner liner and an outer cover.
16. The stent of claim 15, further comprising:
a wire spring sandwiched between the inner liner and the outer cover,
wherein the spiral-shaped opening is defined by slits formed in the inner liner and the outer cover, between a plurality of coils of the wire spring.
17. The stent of claim 16 wherein the wire spring comprises a metal alloy.
18. The stent of claim 17 wherein the metal alloy comprises at least one of titanium, nickel, copper, cobalt, vanadium, and iron.
19. The stent of claim 17 wherein the metal alloy comprises nitonol.
20. The stent of claim 19 wherein nitonol comprises nickel and titanium.
21. The stent of claim 15 wherein at least one of the inner liner and the outer cover comprises a polymer.
22. The stent of claim 21 wherein the polymer comprises at least one of urethane, nylon, thermoplastic polyurethane (TPU), thermoplastic polyester elastomer, polyethyl, and silicone.
23. The stent of claim 1, further comprising:
a removable introducer sized for placement within the lumen.
24. A ureteral stent comprising:
an elongated member defining a lumen, the member having a solid sidewall with at least one slit formed therein such that the member is linearly expandable along a longitudinal axis of the lumen;
a distal retention structure connected to a distal end of the elongated member for retention in a kidney; and
a proximal retention structure connected to a proximal end of the elongated member for retention in a bladder.
25. A method of facilitating urinary drainage from a kidney to a bladder in a patient that reduces discomfort to the patient, comprising:
positioning a ureteral stent in a ureter of a patient, the ureteral stent having an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen, a distal retention structure connected to a distal end of the elongated member for retention in the kidney, and a proximal retention structure connected to a proximal end of the elongated member for retention in the bladder; and
allowing the elongated member to linearly expand and contract between an expanded position and a retracted position, based on at least one of: relative positioning of organs within the patient, a breathing pattern of the patient, and relative positions of the kidney and the bladder.
26. The method of claim 25 wherein the organs comprise the kidney and the bladder.
27. The method of claim 25 wherein the organs are the kidney and the bladder.
28. The method of claim 25 wherein the allowing step comprises providing the elongated member biased to the retracted position.
29. A method of manufacturing a linearly expandable ureteral stent, comprising the steps of:
providing an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen, a distal retention structure, and a proximal retention structure;
connecting the distal retention structure to a distal end of the elongated member; and
connecting the proximal retention structure to a proximal end of the elongated member.
30. The method of claim 29 wherein providing the elongated member comprises providing a wire spring.
31. The method of claim 30 wherein providing the wire spring comprises coating the wire spring with a polymer.
32. The method of claim 30 wherein providing the wire spring comprises sandwiching the wire spring between an inner lining and an outer cover.
33. The method of claim 32 wherein the inner lining and outer cover comprise extruded sheets.
34. The method of claim 32, further comprising;
shrinking the inner lining and outer cover; and
forming slits through the inner lining and outer cover between a plurality of coils of the wire spring.
35. The method of claim 32, further comprising:
melting the inner lining and the outer cover; and
forming slits through the inner lining and outer cover between a plurality of coils of the wire spring.
36. The method of claim 29 wherein providing the elongated member comprises forming a tube comprising a polymer and forming a spiral slit through the tube.
37. A method of placing a ureteral stent in a patient, the method comprising:
providing a ureteral stent comprising:
an elongated member defining a lumen, the member having a solid sidewall defining a spiral-shaped opening such that the member is linearly expandable along a longitudinal axis of the lumen;
a distal retention structure connected to a distal end of the elongated member; and
a proximal retention structure connected to a proximal end of the elongated member;
inserting the ureteral stent into a ureter of the patient; and
positioning the ureteral stent in the patient with the distal retention structure substantially within the kidney of the patient, the elongated member substantially within the intramural tunnel portion of the ureter, and the proximal retention structure substantially within the bladder of the patient.
38. The method of claim 37 wherein the ureteral stent further comprises a removable introducer sized to fit within the lumen and inserting the ureteral stent includes inserting the stent with the removable introducer into the ureter.
US10/283,873 2002-10-30 2002-10-30 Linearly expandable ureteral stent Abandoned US20040087886A1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US10/283,873 US20040087886A1 (en) 2002-10-30 2002-10-30 Linearly expandable ureteral stent
JP2004550158A JP2006504487A (en) 2002-10-30 2003-10-28 Linearly expandable ureteral stent
EP03779375.9A EP1556115B1 (en) 2002-10-30 2003-10-28 Linearly expandable ureteral stent
CA002504150A CA2504150A1 (en) 2002-10-30 2003-10-28 Linearly expandable ureteral stent
PCT/US2003/034214 WO2004041345A1 (en) 2002-10-30 2003-10-28 Linearly expandable ureteral stent
AU2003285060A AU2003285060A1 (en) 2002-10-30 2003-10-28 Linearly expandable ureteral stent
US12/241,450 US9060888B2 (en) 2002-10-30 2008-09-30 Method of disposing a linearly expandable ureteral stent within a patient
US12/628,289 US10201441B2 (en) 2002-10-30 2009-12-01 Linearly expandable ureteral stent
US12/628,304 US8007702B2 (en) 2002-10-30 2009-12-01 Methods of manufacturing linearly expandable ureteral stents
US13/205,440 US8241548B2 (en) 2002-10-30 2011-08-08 Methods of manufacturing linearly expandable ureteral stents
US13/556,864 US8568643B2 (en) 2002-10-30 2012-07-24 Methods of manufacturing linearly expandable ureteral stents
US16/223,375 US11000391B2 (en) 2002-10-30 2018-12-18 Linearly expandable ureteral stent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/283,873 US20040087886A1 (en) 2002-10-30 2002-10-30 Linearly expandable ureteral stent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/241,450 Division US9060888B2 (en) 2002-10-30 2008-09-30 Method of disposing a linearly expandable ureteral stent within a patient

Publications (1)

Publication Number Publication Date
US20040087886A1 true US20040087886A1 (en) 2004-05-06

Family

ID=32174761

Family Applications (7)

Application Number Title Priority Date Filing Date
US10/283,873 Abandoned US20040087886A1 (en) 2002-10-30 2002-10-30 Linearly expandable ureteral stent
US12/241,450 Active 2025-03-24 US9060888B2 (en) 2002-10-30 2008-09-30 Method of disposing a linearly expandable ureteral stent within a patient
US12/628,289 Active 2025-07-04 US10201441B2 (en) 2002-10-30 2009-12-01 Linearly expandable ureteral stent
US12/628,304 Expired - Fee Related US8007702B2 (en) 2002-10-30 2009-12-01 Methods of manufacturing linearly expandable ureteral stents
US13/205,440 Expired - Lifetime US8241548B2 (en) 2002-10-30 2011-08-08 Methods of manufacturing linearly expandable ureteral stents
US13/556,864 Expired - Fee Related US8568643B2 (en) 2002-10-30 2012-07-24 Methods of manufacturing linearly expandable ureteral stents
US16/223,375 Expired - Lifetime US11000391B2 (en) 2002-10-30 2018-12-18 Linearly expandable ureteral stent

Family Applications After (6)

Application Number Title Priority Date Filing Date
US12/241,450 Active 2025-03-24 US9060888B2 (en) 2002-10-30 2008-09-30 Method of disposing a linearly expandable ureteral stent within a patient
US12/628,289 Active 2025-07-04 US10201441B2 (en) 2002-10-30 2009-12-01 Linearly expandable ureteral stent
US12/628,304 Expired - Fee Related US8007702B2 (en) 2002-10-30 2009-12-01 Methods of manufacturing linearly expandable ureteral stents
US13/205,440 Expired - Lifetime US8241548B2 (en) 2002-10-30 2011-08-08 Methods of manufacturing linearly expandable ureteral stents
US13/556,864 Expired - Fee Related US8568643B2 (en) 2002-10-30 2012-07-24 Methods of manufacturing linearly expandable ureteral stents
US16/223,375 Expired - Lifetime US11000391B2 (en) 2002-10-30 2018-12-18 Linearly expandable ureteral stent

Country Status (6)

Country Link
US (7) US20040087886A1 (en)
EP (1) EP1556115B1 (en)
JP (1) JP2006504487A (en)
AU (1) AU2003285060A1 (en)
CA (1) CA2504150A1 (en)
WO (1) WO2004041345A1 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040143209A1 (en) * 2003-01-22 2004-07-22 Liu Clifford M. Ureteral stent configured for improved patient comfort and aftercare
US20050240277A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent with flexible elements
US20050240278A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent improvements
US20050240141A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent kidney curl improvements
US20050240280A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Ureteral stent
US20070050006A1 (en) * 2005-08-31 2007-03-01 Cook Ireland Limited Coaxial dilatation method for stent implantation
US20070078446A1 (en) * 2005-08-31 2007-04-05 Cook Ireland Limited And Cook Incorporated Stent for implantation
WO2007135564A2 (en) * 2006-05-22 2007-11-29 Marian Devonec Prostatic stent
US20070276466A1 (en) * 2005-08-31 2007-11-29 Vance Products Inc., D/B/A/ Cook Urological Inc. Stent for implantation
US20110251671A1 (en) * 2008-10-10 2011-10-13 Kevin Heraty Stent suitable for deployment in a blood vessel
AU2006284819B2 (en) * 2005-08-31 2012-02-02 Cook Medical Technologies Llc Coaxial dilatation method for stent implantation
US20120158025A1 (en) * 2010-12-15 2012-06-21 Christopher Anderson Anastomosis device and related methods
EP2489334A1 (en) * 2010-03-26 2012-08-22 Olympus Medical Systems Corp. Medical stent
EP2567727A1 (en) * 2011-09-06 2013-03-13 Cook Medical Technologies LLC Electrically charged medical device
EP2609892A1 (en) * 2011-12-28 2013-07-03 Cook Medical Technologies LLC Ureteral stent
CN104001257A (en) * 2014-06-13 2014-08-27 胡冰 Double-pigtail stent placed in left hepatic duct of human body
WO2014151557A3 (en) * 2013-03-15 2014-11-13 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US20150005864A1 (en) * 2013-06-28 2015-01-01 Gadelius Medical, K. K. Stent kit
US8961468B2 (en) * 2008-06-25 2015-02-24 Covidien Lp Access assembly
US9108017B2 (en) 2011-03-22 2015-08-18 Applied Medical Resources Corporation Method of making tubing have drainage holes
US9192403B2 (en) 2008-09-12 2015-11-24 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
CN105148383A (en) * 2015-10-30 2015-12-16 济南中康顺医疗器械有限公司 Double-J tube and preparation method thereof
US20160015509A1 (en) * 2014-07-21 2016-01-21 Ardle Tomás McDonough Implantable stent
EP3045201A1 (en) * 2015-01-13 2016-07-20 Cook Medical Technologies LLC Ureteral stent with sideports
US9402971B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US9402632B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9474533B2 (en) 2006-03-13 2016-10-25 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US9498356B2 (en) 2012-12-19 2016-11-22 Cook Medical Technologies, LLC Flexible stent and delivery system
US9763814B2 (en) 2014-10-24 2017-09-19 Cook Medical Technologies Llc Elongate medical device
RU174102U1 (en) * 2016-11-01 2017-10-02 Александр Александрович Соколов Device for intraoperative ureteral stenting with laparoscopic ureteroureteroanastomosis
WO2017180386A1 (en) * 2016-04-11 2017-10-19 Baylor College Of Medicine Removable ureteral stents and methods of use of the same
US9907641B2 (en) 2014-01-10 2018-03-06 W. L. Gore & Associates, Inc. Implantable intraluminal device
US20180126129A1 (en) * 2014-07-21 2018-05-10 Stentorium Ltd Implantable Stent
WO2018085624A1 (en) * 2016-11-04 2018-05-11 Boston Scientific Scimed, Inc. Controlled extension stent
WO2018200060A1 (en) * 2017-04-27 2018-11-01 Whitmore Willet F Iii Dynamic length ureteral stent for improved patient comfort
EP3297573A4 (en) * 2015-05-20 2019-02-20 Innoventions Ltd. Stent and method of use
US10285802B2 (en) * 2016-08-16 2019-05-14 Novartis Ag Devices, systems, and methods for trabecular meshwork extension
US10300244B2 (en) * 2013-07-22 2019-05-28 Renalsense Ltd. Unravelable catheter
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US10610664B2 (en) * 2015-07-20 2020-04-07 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
WO2020086124A1 (en) * 2018-10-22 2020-04-30 Askeland Eric Variable length stent
US10751205B1 (en) 2013-03-05 2020-08-25 W. L. Gore & Associates, Inc. Tapered sleeve
US20210052403A1 (en) * 2019-08-23 2021-02-25 Boston Scientific Scimed, Inc. Devices, systems, and methods for delivering a stent
US11096774B2 (en) 2016-12-09 2021-08-24 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
US11229539B2 (en) 2011-08-12 2022-01-25 W. L. Gore & Associates, Inc. Evertable sheath devices, systems, and methods
US11517371B2 (en) 2018-06-11 2022-12-06 Boston Scientific Scimed, Inc. Sphincterotomes and methods for using sphincterotomes
US11540933B2 (en) 2017-10-11 2023-01-03 W. L. Gore & Associates, Inc. Implantable medical device constraint and deployment apparatus
US11801155B2 (en) 2014-03-06 2023-10-31 W. L. Gore & Associates, Inc. Implantable medical device constraint and deployment apparatus
US11890213B2 (en) 2019-11-19 2024-02-06 Zenflow, Inc. Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040087886A1 (en) 2002-10-30 2004-05-06 Scimed Life Systems, Inc. Linearly expandable ureteral stent
DE202005001416U1 (en) 2005-01-28 2005-03-31 Urovision Ges Fuer Medizinisch stent
JP5805369B2 (en) * 2007-03-20 2015-11-04 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Urological medical devices for releasing therapeutic agents
US8956419B2 (en) 2007-05-14 2015-02-17 Boston Scientific Scimed, Inc. Open lumen stent
US7740604B2 (en) 2007-09-24 2010-06-22 Ivantis, Inc. Ocular implants for placement in schlemm's canal
US20170360609A9 (en) 2007-09-24 2017-12-21 Ivantis, Inc. Methods and devices for increasing aqueous humor outflow
US8734377B2 (en) 2007-09-24 2014-05-27 Ivantis, Inc. Ocular implants with asymmetric flexibility
US20090082862A1 (en) 2007-09-24 2009-03-26 Schieber Andrew T Ocular Implant Architectures
US8808222B2 (en) 2007-11-20 2014-08-19 Ivantis, Inc. Methods and apparatus for delivering ocular implants into the eye
US8512404B2 (en) * 2007-11-20 2013-08-20 Ivantis, Inc. Ocular implant delivery system and method
JP2011513002A (en) 2008-03-05 2011-04-28 イバンティス インコーポレイテッド Method and apparatus for treating glaucoma
US8231686B2 (en) * 2008-06-11 2012-07-31 Eric Mangiardi Stent
US8246691B2 (en) * 2008-06-11 2012-08-21 Eric Mangiardi Stent
WO2010033592A1 (en) * 2008-09-16 2010-03-25 C.R. Bard, Inc. Stent
WO2010032931A2 (en) * 2008-09-19 2010-03-25 Chung Hwan-Hoon Metal stent for the ureter
US8509894B2 (en) * 2008-10-10 2013-08-13 Milux Holding Sa Heart help device, system, and method
US20100100170A1 (en) * 2008-10-22 2010-04-22 Boston Scientific Scimed, Inc. Shape memory tubular stent with grooves
CN102238926B (en) 2008-12-05 2015-09-16 伊万提斯公司 For ocular implants being transported to the method and apparatus in eyes
AU2010271274B2 (en) 2009-07-09 2015-05-21 Alcon Inc. Single operator device for delivering an ocular implant
AU2010271218B2 (en) 2009-07-09 2017-02-02 Alcon Inc. Ocular implants and methods for delivering ocular implants into the eye
EP2490621A4 (en) 2009-10-23 2013-04-03 Ivantis Inc Ocular implant system and method
WO2011163505A1 (en) 2010-06-23 2011-12-29 Ivantis, Inc. Ocular implants deployed in schlemm's canal of the eye
US10219889B2 (en) * 2011-06-10 2019-03-05 Boston Scientific Scimed, Inc. Balloon expandable ureteral stent
US8657776B2 (en) 2011-06-14 2014-02-25 Ivantis, Inc. Ocular implants for delivery into the eye
US8465551B1 (en) * 2011-07-09 2013-06-18 Bandula Wijay Temporary prostatic stent for benign prostatic hyperplasia
US8663150B2 (en) 2011-12-19 2014-03-04 Ivantis, Inc. Delivering ocular implants into the eye
US9358156B2 (en) 2012-04-18 2016-06-07 Invantis, Inc. Ocular implants for delivery into an anterior chamber of the eye
US10596389B2 (en) 2012-05-25 2020-03-24 Ojai Retinal Technology, Llc Process and system for utilizing energy to treat biological tissue
US11077318B2 (en) 2012-05-25 2021-08-03 Ojai Retinal Technology, Llc System and process of utilizing energy for treating biological tissue
US9381116B2 (en) 2012-05-25 2016-07-05 Ojai Retinal Technology, Llc Subthreshold micropulse laser prophylactic treatment for chronic progressive retinal diseases
US10874873B2 (en) 2012-05-25 2020-12-29 Ojai Retinal Technology, Llc Process utilizing pulsed energy to heat treat biological tissue
DE102012013338B4 (en) 2012-07-06 2019-09-26 Heraeus Deutschland GmbH & Co. KG Process for producing an electrode structure
US9254203B2 (en) 2012-08-20 2016-02-09 Boston Scientific Scimed, Inc. Delivery device
US10617558B2 (en) 2012-11-28 2020-04-14 Ivantis, Inc. Apparatus for delivering ocular implants into an anterior chamber of the eye
FR2999416A1 (en) * 2012-12-19 2014-06-20 Benoit Vogt IMPROVED ENDO-URETERAL PROBE
US9415196B2 (en) * 2013-03-13 2016-08-16 Boston Scientific Scimed, Inc. Pancreatic stent drainage system
CN106456866B (en) * 2014-06-15 2019-09-24 派拉盖特医疗有限公司 Continuous implanted peritoneal dialysis
WO2016011056A1 (en) 2014-07-14 2016-01-21 Ivantis, Inc. Ocular implant delivery system and method
CA2961664C (en) 2014-10-09 2020-04-14 Boston Scientific Scimed, Inc. Pancreatic stent with drainage feature
SG10201908628QA (en) * 2015-03-19 2019-11-28 Univ Nanyang Tech A stent assembly and method of preparing the stent assembly
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US10765834B2 (en) 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
EP4265231A3 (en) 2015-08-14 2023-12-20 Alcon Inc. Ocular implant with pressure sensor
BR112018005267A2 (en) * 2015-10-23 2018-10-09 Ojai Retinal Tech Llc process for performing phototherapy or retinal photostimulation, and system for performing phototherapy or retinal photostimulation
US10517710B2 (en) 2015-12-03 2019-12-31 Cook Medical Technologies Llc Helical hollow strand ureteral stent
TWI675676B (en) * 2016-07-22 2019-11-01 邦特生物科技股份有限公司 Drainage system
EP3634516A1 (en) 2017-05-14 2020-04-15 Paragate Medical Ltd. Implantable fluid extraction system
JP7348292B2 (en) 2019-01-07 2023-09-20 ボストン サイエンティフィック サイムド,インコーポレイテッド Stent with anti-migration mechanism
JP2023551927A (en) 2020-12-02 2023-12-13 ボストン サイエンティフィック サイムド,インコーポレイテッド Stents with improved deployment characteristics
JP2024503989A (en) 2021-01-11 2024-01-30 アルコン インコーポレイティド Systems and methods for viscoelastic delivery

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4531933A (en) * 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4643716A (en) * 1984-09-26 1987-02-17 The Kendall Company Multi-size ureteral stent
US4671795A (en) * 1984-11-19 1987-06-09 Mulchin William L Permanent/retrievable ureteral catheter
US4681570A (en) * 1985-12-26 1987-07-21 Dalton Michael J Peritoneal catheter
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US5057114A (en) * 1990-09-18 1991-10-15 Cook Incorporated Medical retrieval basket
US5116309A (en) * 1989-01-25 1992-05-26 Coll Milton E Ureteral stent-catheter system having varying diameter stent
US5129910A (en) * 1991-07-26 1992-07-14 The Regents Of The University Of California Stone expulsion stent
US5282860A (en) * 1991-10-16 1994-02-01 Olympus Optical Co., Ltd. Stent tube for medical use
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5554189A (en) * 1994-02-25 1996-09-10 De La Torre; Fernando I. Ureteral prosthesis
US5562641A (en) * 1993-05-28 1996-10-08 A Bromberg & Co. Ltd. Two way shape memory alloy medical stent
US5647843A (en) * 1996-05-24 1997-07-15 Vance Products Incorporated Anti-reflux ureteral stent
US5681274A (en) * 1995-03-31 1997-10-28 Boston Scientific Corporation Variable length uretheral stent
US5782916A (en) * 1996-08-13 1998-07-21 Galt Laboratories, Inc. Device for maintaining urinary continence
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US5962007A (en) * 1997-12-19 1999-10-05 Indigo Medical, Inc. Use of a multi-component coil medical construct
US5964744A (en) * 1993-01-04 1999-10-12 Menlo Care, Inc. Polymeric medical device systems having shape memory
US6019779A (en) * 1998-10-09 2000-02-01 Intratherapeutics Inc. Multi-filar coil medical stent
US6027516A (en) * 1995-05-04 2000-02-22 The United States Of America As Represented By The Department Of Health And Human Services Highly elastic, adjustable helical coil stent
US6214042B1 (en) * 1998-11-10 2001-04-10 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
US6241691B1 (en) * 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US6306105B1 (en) * 1998-05-14 2001-10-23 Scimed Life Systems, Inc. High performance coil wire
US6332892B1 (en) * 1999-03-02 2001-12-25 Scimed Life Systems, Inc. Medical device with one or more helical coils
US20020183852A1 (en) * 2001-06-01 2002-12-05 Mcweeney John O. Compressible ureteral stent for comfort
US20030040803A1 (en) * 2001-08-23 2003-02-27 Rioux Robert F. Maintaining an open passageway through a body lumen
US20030171708A1 (en) * 2002-03-07 2003-09-11 Joseph Segura Ureteral stent
US20030176831A1 (en) * 2002-03-18 2003-09-18 Gellman Barry N. Expandable ureteral stent
US20030181842A1 (en) * 2002-03-19 2003-09-25 Scimed Life Systems, Inc. Stent retention element and related methods

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US550238A (en) * 1895-11-26 Horace russel allen
GB1267843A (en) * 1969-10-13 1972-03-22 Tmm Research Ltd Improvements in textile spinning machines
SE397769B (en) * 1974-11-04 1977-11-21 Gambro Ab INITIATIVE ELEMENTS FOR USE IN VEHICLE SURGERY AND METHODS OF PRODUCING SUCCESSFUL
US4212304A (en) * 1978-04-07 1980-07-15 Medical Engineering Corp. Uretheral catheter stent
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4660560A (en) * 1985-05-30 1987-04-28 The Beth Israel Hospital Association Method for treating obstructive prostatism
DE3532653C2 (en) * 1985-09-13 1993-10-21 Martin Kaltenbach Dilatation catheter
US4874360A (en) * 1988-07-01 1989-10-17 Medical Engineering Corporation Ureteral stent system
US6171338B1 (en) * 1988-11-10 2001-01-09 Biocon, Oy Biodegradable surgical implants and devices
US5059169A (en) * 1989-07-07 1991-10-22 C. R. Bard, Inc. High-friction prostatic stent
IL94138A (en) * 1990-04-19 1997-03-18 Instent Inc Device for the treatment of constricted fluid conducting ducts
US5098440A (en) * 1990-08-14 1992-03-24 Cordis Corporation Object retrieval method and apparatus
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US6059825A (en) * 1992-03-05 2000-05-09 Angiodynamics, Inc. Clot filter
US5772668A (en) * 1992-06-18 1998-06-30 American Biomed, Inc. Apparatus for placing an endoprosthesis
US5599291A (en) * 1993-01-04 1997-02-04 Menlo Care, Inc. Softening expanding ureteral stent
US5716410A (en) * 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
US5789047A (en) * 1993-12-21 1998-08-04 Japan Gore-Tex, Inc Flexible, multilayered tube
US5531741A (en) * 1994-08-18 1996-07-02 Barbacci; Josephine A. Illuminated stents
US5572819A (en) * 1994-08-25 1996-11-12 Topinka; Ferdinand Light bulb or lighting element protector apparatus with rotatably adjustable cage assembly and which provides information
US5613973A (en) * 1995-03-10 1997-03-25 Wilson Greatbatch Ltd. Laraposcopic surgical grasper having an attachable strap
US5562678A (en) * 1995-06-02 1996-10-08 Cook Pacemaker Corporation Needle's eye snare
US5814006A (en) * 1996-05-28 1998-09-29 Planz; Konrad Temporary stent in the urine path
US5944701A (en) * 1996-10-03 1999-08-31 Dubrul; William R. Self coiling catheter
US6258119B1 (en) * 1996-11-07 2001-07-10 Myocardial Stents, Inc. Implant device for trans myocardial revascularization
DE19703482A1 (en) * 1997-01-31 1998-08-06 Ernst Peter Prof Dr M Strecker Stent
US6395021B1 (en) * 1997-02-26 2002-05-28 Applied Medical Resources Corporation Ureteral stent system apparatus and method
US5795319A (en) * 1997-03-07 1998-08-18 Circon Corporation Easily removable ureteral stent
US6458092B1 (en) * 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
AU1361901A (en) * 1999-11-03 2001-05-14 Endocare, Inc. Method of loading a stent on a delivery catheter
US7169187B2 (en) * 1999-12-22 2007-01-30 Ethicon, Inc. Biodegradable stent
US6338739B1 (en) * 1999-12-22 2002-01-15 Ethicon, Inc. Biodegradable stent
EP1259191A4 (en) * 2000-02-15 2007-02-14 Eva Corp Temporary stent assembly for use in a surgical procedure
AU2001289310B2 (en) * 2000-04-11 2006-07-06 Boston Scientific Limited Reinforced retention structures
US6764519B2 (en) * 2000-05-26 2004-07-20 Scimed Life Systems, Inc. Ureteral stent
GB0012764D0 (en) 2000-05-26 2000-07-19 Tayside University Hospitals N G-stent
US6976973B1 (en) * 2000-10-12 2005-12-20 Baxter International Inc. Peritoneal dialysis catheters
US6458145B1 (en) * 2000-11-28 2002-10-01 Hatch Medical L.L.C. Intra vascular snare and method of forming the same
US6719804B2 (en) * 2001-04-02 2004-04-13 Scimed Life Systems, Inc. Medical stent and related methods
US6790223B2 (en) * 2001-09-21 2004-09-14 Scimed Life Systems, Inc. Delivering a uretheral stent
US6620202B2 (en) * 2001-10-16 2003-09-16 Scimed Life Systems, Inc. Medical stent with variable coil and related methods
DE10155767B4 (en) * 2001-11-14 2004-07-15 Walter, Thomas, Dr. ureter
US7041139B2 (en) * 2001-12-11 2006-05-09 Boston Scientific Scimed, Inc. Ureteral stents and related methods
US20030191492A1 (en) * 2002-04-05 2003-10-09 Scimed Life Systems, Inc. Radial coil expandable medical wire
US6949125B2 (en) * 2002-04-16 2005-09-27 Boston Scientific Scimed, Inc. Ureteral stent with end-effector and related methods
US7485150B2 (en) * 2002-04-23 2009-02-03 Boston Scientific Scimed, Inc. Drainage devices and methods
US7122048B2 (en) * 2002-05-03 2006-10-17 Scimed Life Systems, Inc. Hypotube endoluminal device
US6733536B1 (en) * 2002-10-22 2004-05-11 Scimed Life Systems Male urethral stent device
US20040087886A1 (en) * 2002-10-30 2004-05-06 Scimed Life Systems, Inc. Linearly expandable ureteral stent
US7044981B2 (en) * 2003-01-22 2006-05-16 Boston Scientific Scimed, Inc. Ureteral stent configured for improved patient comfort and aftercare
US6929664B2 (en) * 2003-12-05 2005-08-16 Fossa Medical, Inc. Open lumen stents
GB0409031D0 (en) 2004-04-23 2004-05-26 Ravi P K Stents
US7507218B2 (en) * 2004-04-26 2009-03-24 Gyrus Acmi, Inc. Stent with flexible elements
US7524329B2 (en) * 2005-02-08 2009-04-28 Wilson-Cook Medical Inc. Self contracting stent
US7550012B2 (en) * 2005-08-31 2009-06-23 Cook Ireland Limited Stent for implantation
US9017395B2 (en) * 2007-03-09 2015-04-28 Novostent Corporation Vascular prosthesis and methods of use
WO2018085624A1 (en) * 2016-11-04 2018-05-11 Boston Scientific Scimed, Inc. Controlled extension stent

Patent Citations (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4531933A (en) * 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4643716A (en) * 1984-09-26 1987-02-17 The Kendall Company Multi-size ureteral stent
US4671795A (en) * 1984-11-19 1987-06-09 Mulchin William L Permanent/retrievable ureteral catheter
US4681570A (en) * 1985-12-26 1987-07-21 Dalton Michael J Peritoneal catheter
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US5116309A (en) * 1989-01-25 1992-05-26 Coll Milton E Ureteral stent-catheter system having varying diameter stent
US5057114A (en) * 1990-09-18 1991-10-15 Cook Incorporated Medical retrieval basket
US5129910A (en) * 1991-07-26 1992-07-14 The Regents Of The University Of California Stone expulsion stent
US5282860A (en) * 1991-10-16 1994-02-01 Olympus Optical Co., Ltd. Stent tube for medical use
US5964744A (en) * 1993-01-04 1999-10-12 Menlo Care, Inc. Polymeric medical device systems having shape memory
US5562641A (en) * 1993-05-28 1996-10-08 A Bromberg & Co. Ltd. Two way shape memory alloy medical stent
US5554189A (en) * 1994-02-25 1996-09-10 De La Torre; Fernando I. Ureteral prosthesis
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5681274A (en) * 1995-03-31 1997-10-28 Boston Scientific Corporation Variable length uretheral stent
US6027516A (en) * 1995-05-04 2000-02-22 The United States Of America As Represented By The Department Of Health And Human Services Highly elastic, adjustable helical coil stent
US5647843A (en) * 1996-05-24 1997-07-15 Vance Products Incorporated Anti-reflux ureteral stent
US5782916A (en) * 1996-08-13 1998-07-21 Galt Laboratories, Inc. Device for maintaining urinary continence
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US6241691B1 (en) * 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US5962007A (en) * 1997-12-19 1999-10-05 Indigo Medical, Inc. Use of a multi-component coil medical construct
US6306105B1 (en) * 1998-05-14 2001-10-23 Scimed Life Systems, Inc. High performance coil wire
US6019779A (en) * 1998-10-09 2000-02-01 Intratherapeutics Inc. Multi-filar coil medical stent
US6214042B1 (en) * 1998-11-10 2001-04-10 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
US6332892B1 (en) * 1999-03-02 2001-12-25 Scimed Life Systems, Inc. Medical device with one or more helical coils
US20020183852A1 (en) * 2001-06-01 2002-12-05 Mcweeney John O. Compressible ureteral stent for comfort
US6887215B2 (en) * 2001-06-01 2005-05-03 Boston Scientific Scimed, Inc. Compressible ureteral stent for comfort
US20030040803A1 (en) * 2001-08-23 2003-02-27 Rioux Robert F. Maintaining an open passageway through a body lumen
US20030171708A1 (en) * 2002-03-07 2003-09-11 Joseph Segura Ureteral stent
US20050131547A1 (en) * 2002-03-07 2005-06-16 Joseph Segura Ureteral stent
US20030176831A1 (en) * 2002-03-18 2003-09-18 Gellman Barry N. Expandable ureteral stent
US20030181842A1 (en) * 2002-03-19 2003-09-25 Scimed Life Systems, Inc. Stent retention element and related methods

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7044981B2 (en) * 2003-01-22 2006-05-16 Boston Scientific Scimed, Inc. Ureteral stent configured for improved patient comfort and aftercare
US20040143209A1 (en) * 2003-01-22 2004-07-22 Liu Clifford M. Ureteral stent configured for improved patient comfort and aftercare
US7470247B2 (en) * 2004-04-26 2008-12-30 Gyrus Acmi, Inc. Ureteral stent
US20050240277A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent with flexible elements
US20050240278A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent improvements
US20050240141A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent kidney curl improvements
US20050240280A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Ureteral stent
US7507218B2 (en) 2004-04-26 2009-03-24 Gyrus Acmi, Inc. Stent with flexible elements
US7789915B2 (en) * 2005-08-31 2010-09-07 Vance Products Incorporated Stent for implantation
US20070276466A1 (en) * 2005-08-31 2007-11-29 Vance Products Inc., D/B/A/ Cook Urological Inc. Stent for implantation
US20070050006A1 (en) * 2005-08-31 2007-03-01 Cook Ireland Limited Coaxial dilatation method for stent implantation
AU2006284819B2 (en) * 2005-08-31 2012-02-02 Cook Medical Technologies Llc Coaxial dilatation method for stent implantation
US20070078446A1 (en) * 2005-08-31 2007-04-05 Cook Ireland Limited And Cook Incorporated Stent for implantation
US7550012B2 (en) * 2005-08-31 2009-06-23 Cook Ireland Limited Stent for implantation
US10188397B2 (en) 2006-03-13 2019-01-29 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US9402632B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9474533B2 (en) 2006-03-13 2016-10-25 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US9402971B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
EP3167821B1 (en) * 2006-03-13 2019-10-02 PneumRx, Inc. Lung volume reduction devices
US9782558B2 (en) 2006-03-13 2017-10-10 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US10226257B2 (en) 2006-03-13 2019-03-12 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
WO2007135564A2 (en) * 2006-05-22 2007-11-29 Marian Devonec Prostatic stent
US20090299488A1 (en) * 2006-05-22 2009-12-03 Marian Devonec Prostatic stent
WO2007135564A3 (en) * 2006-05-22 2008-04-17 Marian Devonec Prostatic stent
US8961468B2 (en) * 2008-06-25 2015-02-24 Covidien Lp Access assembly
US10058331B2 (en) 2008-09-12 2018-08-28 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US10285707B2 (en) 2008-09-12 2019-05-14 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US9192403B2 (en) 2008-09-12 2015-11-24 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US20110251671A1 (en) * 2008-10-10 2011-10-13 Kevin Heraty Stent suitable for deployment in a blood vessel
US9149377B2 (en) 2008-10-10 2015-10-06 Veryan Medical Ltd. Stent suitable for deployment in a blood vessel
US9314353B2 (en) * 2008-10-10 2016-04-19 Veryan Medical Limited Stent suitable for deployment in a blood vessel
CN102655824A (en) * 2010-03-26 2012-09-05 奥林巴斯医疗株式会社 Medical stent
US8632606B2 (en) 2010-03-26 2014-01-21 Olympus Medical Systems Corp. Medical stent
US9192493B2 (en) 2010-03-26 2015-11-24 Olympus Corporation Medical stent having a marker coil
EP2489334A1 (en) * 2010-03-26 2012-08-22 Olympus Medical Systems Corp. Medical stent
EP2489334A4 (en) * 2010-03-26 2012-08-22 Olympus Medical Systems Corp Medical stent
EP2803339A1 (en) * 2010-03-26 2014-11-19 Olympus Medical Systems Corp. Medical stent
US20120158025A1 (en) * 2010-12-15 2012-06-21 Christopher Anderson Anastomosis device and related methods
US9108017B2 (en) 2011-03-22 2015-08-18 Applied Medical Resources Corporation Method of making tubing have drainage holes
US11229539B2 (en) 2011-08-12 2022-01-25 W. L. Gore & Associates, Inc. Evertable sheath devices, systems, and methods
US9381102B2 (en) 2011-09-06 2016-07-05 Cook Medical Technologies Llc Electrically charged medical device
EP2567727A1 (en) * 2011-09-06 2013-03-13 Cook Medical Technologies LLC Electrically charged medical device
US9033956B2 (en) 2011-09-06 2015-05-19 Cook Medical Technologies Llc Electrically charged medical device
EP2609892A1 (en) * 2011-12-28 2013-07-03 Cook Medical Technologies LLC Ureteral stent
US9498356B2 (en) 2012-12-19 2016-11-22 Cook Medical Technologies, LLC Flexible stent and delivery system
US10751205B1 (en) 2013-03-05 2020-08-25 W. L. Gore & Associates, Inc. Tapered sleeve
US11903856B1 (en) 2013-03-05 2024-02-20 W. L. Gore & Associates, Inc. Tapered sleeve
WO2014151557A3 (en) * 2013-03-15 2014-11-13 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US9844652B2 (en) * 2013-06-28 2017-12-19 Gadelius Medical, K.K. Stent kit
US20150005864A1 (en) * 2013-06-28 2015-01-01 Gadelius Medical, K. K. Stent kit
US10300244B2 (en) * 2013-07-22 2019-05-28 Renalsense Ltd. Unravelable catheter
US9907641B2 (en) 2014-01-10 2018-03-06 W. L. Gore & Associates, Inc. Implantable intraluminal device
US11166806B2 (en) 2014-01-10 2021-11-09 W. L. Gore & Associates, Inc. Implantable intraluminal device
US11857407B2 (en) 2014-01-10 2024-01-02 W. L. Gore & Associates, Inc. Implantable intraluminal device
US10405966B2 (en) 2014-01-10 2019-09-10 W. L. Gore & Associates, Inc. Implantable intraluminal device
US11801155B2 (en) 2014-03-06 2023-10-31 W. L. Gore & Associates, Inc. Implantable medical device constraint and deployment apparatus
CN104001257A (en) * 2014-06-13 2014-08-27 胡冰 Double-pigtail stent placed in left hepatic duct of human body
US20180126129A1 (en) * 2014-07-21 2018-05-10 Stentorium Ltd Implantable Stent
US20160015509A1 (en) * 2014-07-21 2016-01-21 Ardle Tomás McDonough Implantable stent
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9763814B2 (en) 2014-10-24 2017-09-19 Cook Medical Technologies Llc Elongate medical device
EP3045201A1 (en) * 2015-01-13 2016-07-20 Cook Medical Technologies LLC Ureteral stent with sideports
EP3297573A4 (en) * 2015-05-20 2019-02-20 Innoventions Ltd. Stent and method of use
US10610664B2 (en) * 2015-07-20 2020-04-07 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
CN105148383A (en) * 2015-10-30 2015-12-16 济南中康顺医疗器械有限公司 Double-J tube and preparation method thereof
WO2017180386A1 (en) * 2016-04-11 2017-10-19 Baylor College Of Medicine Removable ureteral stents and methods of use of the same
US10285802B2 (en) * 2016-08-16 2019-05-14 Novartis Ag Devices, systems, and methods for trabecular meshwork extension
RU174102U1 (en) * 2016-11-01 2017-10-02 Александр Александрович Соколов Device for intraoperative ureteral stenting with laparoscopic ureteroureteroanastomosis
WO2018085624A1 (en) * 2016-11-04 2018-05-11 Boston Scientific Scimed, Inc. Controlled extension stent
AU2017353991B2 (en) * 2016-11-04 2019-10-24 Boston Scientific Scimed, Inc. Controlled extension stent
CN109906100A (en) * 2016-11-04 2019-06-18 波士顿科学医学有限公司 Controlled extending bracket
US11213414B2 (en) 2016-11-04 2022-01-04 Boston Scientific Scimed, Inc. Controlled extension stent
US20220079785A1 (en) * 2016-11-04 2022-03-17 Boston Scientific Scimed, Inc. Controlled extension stent
JP2019534754A (en) * 2016-11-04 2019-12-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Controlled stent
US11903859B1 (en) 2016-12-09 2024-02-20 Zenflow, Inc. Methods for deployment of an implant
US11096774B2 (en) 2016-12-09 2021-08-24 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
WO2018200060A1 (en) * 2017-04-27 2018-11-01 Whitmore Willet F Iii Dynamic length ureteral stent for improved patient comfort
US11540933B2 (en) 2017-10-11 2023-01-03 W. L. Gore & Associates, Inc. Implantable medical device constraint and deployment apparatus
US11517371B2 (en) 2018-06-11 2022-12-06 Boston Scientific Scimed, Inc. Sphincterotomes and methods for using sphincterotomes
WO2020086124A1 (en) * 2018-10-22 2020-04-30 Askeland Eric Variable length stent
US11039914B2 (en) 2018-10-22 2021-06-22 Sevro Technologies Llc Variable length stent
US20210052403A1 (en) * 2019-08-23 2021-02-25 Boston Scientific Scimed, Inc. Devices, systems, and methods for delivering a stent
US11890210B2 (en) * 2019-08-23 2024-02-06 Boston Scientific Scimed, Inc. Devices, systems, and methods for delivering a stent
WO2021041235A1 (en) * 2019-08-23 2021-03-04 Boston Scientific Scimed, Inc. Devices, systems, and methods for delivering a stent
US11890213B2 (en) 2019-11-19 2024-02-06 Zenflow, Inc. Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra

Also Published As

Publication number Publication date
US9060888B2 (en) 2015-06-23
AU2003285060A1 (en) 2004-06-07
EP1556115A1 (en) 2005-07-27
US8241548B2 (en) 2012-08-14
US20100072659A1 (en) 2010-03-25
US20100076574A1 (en) 2010-03-25
WO2004041345A1 (en) 2004-05-21
US8007702B2 (en) 2011-08-30
US20090030363A1 (en) 2009-01-29
EP1556115B1 (en) 2017-01-11
US8568643B2 (en) 2013-10-29
US20110290404A1 (en) 2011-12-01
US11000391B2 (en) 2021-05-11
US20120285607A1 (en) 2012-11-15
JP2006504487A (en) 2006-02-09
CA2504150A1 (en) 2004-05-21
US10201441B2 (en) 2019-02-12
US20190117422A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
US11000391B2 (en) Linearly expandable ureteral stent
US6685744B2 (en) Expandable ureteral stent
US5224953A (en) Method for treatment of obstructive portions of urinary passageways
US7842098B2 (en) Longitudinally expanding medical device
US5456667A (en) Temporary stenting catheter with one-piece expandable segment
US7691078B2 (en) Draining bodily fluids with a stent
US20060247576A1 (en) Fluid-Based Agent Delivery Device With Self-Expanding Delivery Element
US20040260381A1 (en) Devices and methods for forming stenting structures in situ
US20040260380A1 (en) Devices for delivering multiple stenting structures in situ
WO2004112653A2 (en) Devices and methods for delivering and forming single and multiple stenting structures in situ
EP3281668B1 (en) Solid wire ureteral stent
JP2002011102A (en) Medical guide wire

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GELLMAN, BARRY N.;REEL/FRAME:013448/0230

Effective date: 20021015

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:017335/0736

Effective date: 20041222

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION